| __timestamp | BioCryst Pharmaceuticals, Inc. | HUTCHMED (China) Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 13486000 | 19764000 |
| Thursday, January 1, 2015 | 46361000 | 67426000 |
| Friday, January 1, 2016 | 23654000 | 59752000 |
| Sunday, January 1, 2017 | 23484000 | 65383000 |
| Monday, January 1, 2018 | 20182000 | 70165000 |
| Tuesday, January 1, 2019 | 44734000 | 44738000 |
| Wednesday, January 1, 2020 | 16136000 | 39457000 |
| Friday, January 1, 2021 | 149906000 | 97894000 |
| Saturday, January 1, 2022 | 264233000 | 115306000 |
| Sunday, January 1, 2023 | 326751000 | 453552000 |
Unleashing insights
In the dynamic world of biopharmaceuticals, financial performance is a key indicator of a company's health and potential. Over the past decade, HUTCHMED (China) Limited and BioCryst Pharmaceuticals, Inc. have showcased intriguing trends in their gross profits. From 2014 to 2023, HUTCHMED's gross profit surged by approximately 2,200%, peaking in 2023. Meanwhile, BioCryst experienced a remarkable growth of around 2,300% during the same period, with a significant leap in 2021.
The year 2023 marked a pivotal point, with HUTCHMED achieving a gross profit of $453 million, surpassing BioCryst's $327 million. This financial journey highlights the resilience and strategic prowess of these companies in navigating the competitive biopharma landscape. As the industry continues to evolve, these trends offer valuable insights into the financial trajectories of leading players.
Key Insights on Gross Profit: Takeda Pharmaceutical Company Limited vs HUTCHMED (China) Limited
Gross Profit Trends Compared: Biogen Inc. vs BioCryst Pharmaceuticals, Inc.
Gross Profit Trends Compared: Incyte Corporation vs HUTCHMED (China) Limited
Viatris Inc. vs HUTCHMED (China) Limited: A Gross Profit Performance Breakdown
Key Insights on Gross Profit: Catalent, Inc. vs BioCryst Pharmaceuticals, Inc.
Gross Profit Trends Compared: Walgreens Boots Alliance, Inc. vs BioCryst Pharmaceuticals, Inc.
Gross Profit Trends Compared: Corcept Therapeutics Incorporated vs HUTCHMED (China) Limited
Key Insights on Gross Profit: Amneal Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.
HUTCHMED (China) Limited and Supernus Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
HUTCHMED (China) Limited and Travere Therapeutics, Inc.: A Detailed Gross Profit Analysis
Who Generates Higher Gross Profit? Supernus Pharmaceuticals, Inc. or BioCryst Pharmaceuticals, Inc.
Gross Profit Comparison: BioCryst Pharmaceuticals, Inc. and Evotec SE Trends